Citeline Podcasts

Five-Minute Podcast: “UK Needs To Align More With The EU”

30 Mar 2026

Contributed by Lukas

A legal firm’s perspective on how the UK should evolve its medtech regulatory system, global harmonization and opportunities to embed best practice ...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 30, 2026

30 Mar 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年3月27当周的生物制药行业的商业动态。本期节目采用人工...

Why Longevity Is The Next Big OTC Opportunity, With Euromonitor’s Magda Starula

30 Mar 2026

Contributed by Lukas

In this episode of HBW Insight’s Over the Counter, we’re digging into one of the most talked‑about themes in consumer health right now: longevit...

Scrip's Five Must-Know Things - Mar.30, 2026

30 Mar 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.27, 2026. This episode was produced with the help ...

Drug Fix: US FDA Commissioner Martin Makary Completes First Year In Charge

27 Mar 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider US Food and Drug Administration Commi...

Lupin’s CEO And MD On GLP-1 Strategy, Business Growth And Legacy

26 Mar 2026

Contributed by Lukas

Lupin’s CEO Vinita Gupta and managing director Nilesh Gupta speak with Citeline’s senior editor Vibha Ravi about their plans for first-in-class an...

Lupin’s CEO And MD On GLP-1 Strategy, Business Growth And Legacy

25 Mar 2026

Contributed by Lukas

Lupin’s CEO Vinita Gupta and managing director Nilesh Gupta speak with Citeline’s senior editor Vibha Ravi about their plans for first-in-class an...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.23, 2026

23 Mar 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年3月20日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Mar.23, 2026

23 Mar 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.13, 2026. This episode was produced with the help of ...

Drug Fix: ACIP Next Steps After Judge Stops Work, Potential Opioid Disposal Changes

20 Mar 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, and Editor-in-Chief Nielsen Hobbs discuss the next steps after a feder...

How a CDMO Created a Custom Vaccine Development Project

19 Mar 2026

Contributed by Lukas

What does it take to move from concept to commercial vaccine manufacturing at speed without compromising quality or compliance? In this conversation, ...

뇌질환 신약 개발 펀딩 부활 조짐 (Korean-language podcast) Mar.19, 2026

19 Mar 2026

Contributed by Lukas

최근 미국의 BIO 투자자 및 성장 서밋에서 투자자들은 초기 단계 신경과학 분야의 자금 조달 환경이 여전히 어렵지...

The Generics Bulletin Podcast: 2026 Conferences

17 Mar 2026

Contributed by Lukas

The final week of February saw the AAM hold its Access! 2026 annual conference in Miami and Medicines for Europe hold its annual regulatory and scient...

Winning In The Probiotics Space, With David Pineda Ereño

16 Mar 2026

Contributed by Lukas

Probiotics remain one of the fastest‑growing segments in consumer health, but companies still face the challenge of operating in a fragmented claims...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.16, 2026

16 Mar 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年3月13日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Mar.16, 2026

16 Mar 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.13, 2026. This episode was produced with the help of ...

Drug Fix: US FDA’s Prasad Leaves, Harry Potter, And Is CNPV Effective Because Of RTOR?

13 Mar 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman and Editor-in-Chief Nielsen Hobbs discuss potential directions for the ...

Killing Cancer Loudly: Onchilles Pharma's Neutrophil-Derived Path to Pan-Cancer Therapy

11 Mar 2026

Contributed by Lukas

What if a drug could kill cancer cells broadly, spare the immune system and then train it to keep fighting, without triggering resistance? That's the ...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.9, 2026

09 Mar 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年3月6日当周的生物制药行业的商业动态。本期节目采用人工...

Scrip's Five Must-Know Things - Mar.9, 2026

09 Mar 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.6, 2026. This episode was produced with the help of A...

Drug Fix: The State Of Facility Inspections With Two Former Senior US FDA Execs

06 Mar 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery and Senior Editor Sue Sutter are joined by special guests Michael Rogers, former US Food and Drug Administ...

Unpacking Europe’s Probiotic Rules with David Pineda Ereño

02 Mar 2026

Contributed by Lukas

The European market for probiotic dietary supplements is one of the most dynamic, but also one of the most complicated, areas of self‑care right now...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 2, 2026

02 Mar 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年3月2日当周的生物制药行业的商业动态。本期节目采用人工...

Scrip's Five Must-Know Things - Mar.2, 2026

02 Mar 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended Feb.27, 2026. This episode was produced with the help of ...

Drug Fix: State Of The Generics Industry, US FDA Commissioner On Compassionate Use

27 Feb 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Editor-in-Chief Nielsen Hobbs and special guest Dave Wallace, executive editor of Generics Bulletin, disc...

Affibody and the Case for Antibody Mimetics in Radioligand Therapy

25 Feb 2026

Contributed by Lukas

Swedish biotech Affibody has spent over two decades engineering proteins 1/20th the size of a conventional monoclonal antibody — and CEO David Bejke...

글로벌 제약업계, 2026년 역풍 직면…최혜국 약가정책 영향은 제한적 (Korean-language podcast) Feb.25, 2026

25 Feb 2026

Contributed by Lukas

특허 만료와 미국 내 약가 압박은 대형 글로벌 제약사들이 극복해야 할 과제이며, 다수 제약사가 올해 소폭의 실적...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 24, 2026

24 Feb 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年2月20日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Feb.24, 2026

24 Feb 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended February 20, 2026. This episode was produced with the hel...

Drug Fix: ‘America First’ US FDA User Fees, Moderna’s Flu Vaccine Saga Continues

20 Feb 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss a ...

Hansa Biopharma On Clearing The Path To Kidney Transplant

16 Feb 2026

Contributed by Lukas

Renée Aguiar-Lucander, CEO of Hansa Biopharma, discussed the company’s leading asset, its journey toward US FDA approval and the trials and tribula...

ESG, Eco‑Pricing and Sustainable Packaging, with Steve Ramus

16 Feb 2026

Contributed by Lukas

In Part 2 of HBW Insight’s conversation with sustainability leader Steve Ramus, we dig into the practical realities shaping the future of sustainabi...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 16, 2026

16 Feb 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年2月13日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Feb.16, 2026

16 Feb 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended February 13, 2026. This episode was produced with the hel...

Drug Fix: US FDA Versus Moderna And The Changing Role Of Refuse To File Actions

13 Feb 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss the...

Preventing Lung Disease in Preterm Babies

09 Feb 2026

Contributed by Lukas

Bronchopulmonary dysplasia affects up to 90% of extremely preterm infants, yet no approved therapies exist. In this episode of the In Vivo podcast, Ai...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 9 , 2026

09 Feb 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年2月6日当周的生物制药行业的商业动态。本期节目采用人工...

Scrip's Five Must-Know Things - Feb. 9, 2026

09 Feb 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended February 60, 2026. This episode was produced with the hel...

Drug Fix: US FDA Hiring Improves, But Can The Agency Avoid Oversight Erosion?

06 Feb 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the impact of new data showing US Foo...

Navigating A Changing EU And US Sustainability Landscape, With Steve Ramus

02 Feb 2026

Contributed by Lukas

With the European Union rolling back parts of its Green Deal — including scaling back major legislation such as the Corporate Sustainability Reporti...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb.2, 2026

02 Feb 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年1月30日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Feb. 2, 2026

02 Feb 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended January 30, 2026. This episode was produced with the help...

Drug Fix: Understanding US FDA’s CNPV Application Reviews

30 Jan 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss details recently unearthed about the r...

How Senti Bio's Programmable Cell Therapy Tackles AML's Toxicity Problem

27 Jan 2026

Contributed by Lukas

Tim Lu, CEO of Senti Bio, joins In Vivo to discuss how programmable cell therapies are solving oncology's targeting problem. Lu explains the logic-gat...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

26 Jan 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年1月23日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Jan. 26, 2026

26 Jan 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended January 23, 2026. This episode was produced with the help...

Scrip JPM Podcast: Dealmaking, Regulatory And Commercial Expectations For 2026

23 Jan 2026

Contributed by Lukas

Scrip senior editor Jessica Merrill, Scrip US managing editor Mandy Jackson and In Vivo senior reporter David Wild discuss trends and topics from inte...

Drug Fix: US FDA Review Speed Steady In 2025, But Will Staffing Impact In 2026?

23 Jan 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, Managing Editor Bridget Silverman and Editor-in-Chief Nielsen Hobbs consider th...

Herantis’s ‘Elegant’ Approach In Parkinson’s

21 Jan 2026

Contributed by Lukas

Antti Vuolanto, CEO of Herantis Pharma, discusses the significant unmet need in Parkinson’s disease and outlines Phase II plans for the company’s ...

3分で解説 #世界のファーマ】第28回 ノバルティスが警鐘 自国第一主義の弊害へ (Japanese-language podcast)

19 Jan 2026

Contributed by Lukas

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

19 Jan 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年1月16日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Jan. 19, 2026

19 Jan 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended January 16, 2026. This episode was produced with the help...

Drug Fix: Pazdur’s CNPV Problems, Could US FDA Release Unapproved Product Action Packages?

16 Jan 2026

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs consider the many concerns Richard Pazdur and...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

13 Jan 2026

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年1月9日当周的生物制药行业的商业动态。本期节目采用人工...

Scrip이 묻다: 2026년 바이오의약품 업계 전망은? 자본배분과 딜메이킹 (Korean-language podcast)

13 Jan 2026

Contributed by Lukas

Scrip의 2026년 글로벌 제약바이오 산업 전망 (1부: 자본배분과 딜메이킹)을 요약한내용입니다. https://insights.citeline....

Scrip's Five Must-Know Things - Jan. 13, 2026

13 Jan 2026

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended January 9, 2026. This episode was produced with the help ...

Drug Fix: Oncology Stalwart Richard Pazdur Leaves US FDA

09 Jan 2026

Contributed by Lukas

PreVision Policy Founding Member Michael McCaughan joins Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nie...

Building a Nasal First line of Defense Against H5N1

05 Jan 2026

Contributed by Lukas

Intranasal vaccines are back in the spotlight as highly pathogenic avian influenza spreads among birds and spills over into mammals, including recent ...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

22 Dec 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年12月19日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Dec. 22, 2025

22 Dec 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended December 19, 2025. This episode was produced with the hel...

“We Are On The Cusp Of A Real Revolution”: OHC Rare Disease Center Boosts Innovation

19 Dec 2025

Contributed by Lukas

Matthew Wood, director and chief scientific officer at Oxford-Harrington Rare Disease Center, discusses the state of rare disease R&D, the evolving la...

Scrip Awards Podcast, 2025 Winners

19 Dec 2025

Contributed by Lukas

This podcast brings you highlights from Scrip Awards 2025, including wins for AstraZeneca, Syndax, Akeso and Summit Therapeutics and the Lifetime Achi...

Datamonitor Healthcare Podcast: A Deep Dive into Dry AMD

19 Dec 2025

Contributed by Lukas

Emma Wille and Summer Colling speak with ophthalmology expert, Joseph Jacob, to discuss the latest developments in dry age-related macular degeneratio...

Scrip M&A Podcast: PwC's Dealmaking Preview for 2026

16 Dec 2025

Contributed by Lukas

Scrip senior writer Joseph Haas and PwC analyst Roel Van den Akker look back on biopharma sector dealmaking in 2025, why deal values rose from 2024's ...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

15 Dec 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年12月12日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Dec. 15, 2025

15 Dec 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended December 12, 2025. This week, a focus on five key results...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

08 Dec 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年12月5日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Dec. 8, 2025

08 Dec 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended December 5, 2025. In this episode: Trump’s UK drug pric...

Overcoming Drug Resistance In Oncology With Kairos Pharma's Neil Bhowmick

05 Dec 2025

Contributed by Lukas

Drug resistance derails even the most advanced cancer treatments, but what if we could restore sensitivity to existing therapies instead of starting o...

Drug Fix: Understanding the US FDA’s CDER Leadership Shuffle

05 Dec 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs break down the pending retirement of C...

【3分で解説 #世界のファーマ】第27回 中国バイオ企業の成長 5つのテーマ (Japanese-language podcast)

01 Dec 2025

Contributed by Lukas

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

01 Dec 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年11月28日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Dec. 1, 2025

01 Dec 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended November 28, 2025. In this episode: 2027 Medicare price ...

글로벌 바이오 리더들, M&A 열기 속 낙관론 확산 (Korean-language podcast)

28 Nov 2025

Contributed by Lukas

최근 런던에서 열린 Jefferies 글로벌 헬스케어 컨퍼런스를 취재한 Scrip기사를 요약한 내용입니다 https://insights.citel...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

25 Nov 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年11月21日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Nov. 25, 2025

25 Nov 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended November 21, 2025. In this episode: obesity beyond GLP-1s...

Charles River CSO Calls For Collaboration On Non-Animal Models

24 Nov 2025

Contributed by Lukas

Charles River’s CSO Julie Frearson outlines the FDA’s planned transition away from animal testing, changing attitudes to artificial intelligence, ...

Over The Counter Special: Enabling Digital Self-Care, With PAGB’s Michelle Riddalls

19 Nov 2025

Contributed by Lukas

The UK’s consumer healthcare industry association, PAGB is publishing a series of blog posts for Self-Care Week – an annual awareness campaign in ...

Digital Health Roundup: BCIs Surge Ahead, Oura Eyes BP Clearance, AI Faces New Scrutiny

18 Nov 2025

Contributed by Lukas

In this week’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights her interviews with leaders at brain-computer interface developers...

Over The Counter Special: Unlocking Switch-Driven Growth, With PAGB’s Michelle Riddalls

18 Nov 2025

Contributed by Lukas

The UK’s consumer healthcare industry association, PAGB is publishing a series of blog posts for Self-Care Week – an annual awareness campaign in ...

Data-Driven Insights Reveal The Growth Engines Powering 2026 Life Sciences

17 Nov 2025

Contributed by Lukas

In this special In Vivo podcast episode, executive editor Lucie Ellis-Taitt is joined by an expert panel of Citeline journalists – Ashley Yeo, David...

EY's Arda Ural on IPOs, Financial Markets and Tarrifs

13 Nov 2025

Contributed by Lukas

After two of the toughest years in biotech history, are we finally seeing a turnaround? EY's Arda Ural discusses the long-awaited recovery in biotech ...

Datamonitor Healthcare Podcast: ESMO 2025

12 Nov 2025

Contributed by Lukas

Summer Colling and Emma Wille speak with Nkiru Ibeanu, Anna Simmons, and David Dahan from the oncology team about some of the most exciting data prese...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

10 Nov 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年11月1日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Nov. 10, 2025

10 Nov 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended November 1, 2025. In this episode: Pfizer’s unwavering ...

Drug Fix: Examining George Tidmarsh’s Departure As Head Of US FDA’s Drug Center

07 Nov 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs take a deep ...

Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology

06 Nov 2025

Contributed by Lukas

Join Sarah Anderson, Therapeutic Strategy Director, Oncology at Novotech, and Izabela Chmielewska from Citeline as they explore how next-generation im...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

04 Nov 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月31日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Nov. 4, 2025

04 Nov 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended October 31, 2025. In this episode: third quarter dealmaki...

Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform

31 Oct 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the impact of the US Food and Drug Ad...

Decoding Cell Differentiation: How AI Foundation Models Are Reshaping Regenerative Medicine

31 Oct 2025

Contributed by Lukas

What if we could train AI to understand how stem cells become any cell type in the human body? In this episode of the In Vivo Podcast, host David Wild...

Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space?

31 Oct 2025

Contributed by Lukas

Joseph Haas, senior writer, Scrip, speaks to guest panelists Robert Darwin, partner, Sidley law firm, and Arda Ural, Americas Life Sciences Leader, EY...

국내 바이오텍 펀딩 활성화를 위해 새로운 촉매제 필요 (Korean-language podcast)

31 Oct 2025

Contributed by Lukas

스톤브릿지벤쳐스의 김현기 상무는 Scrip과의 인터뷰에서 벤처캐피탈의 국내 바이오 투심 회복을 제약하는 요인과...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

27 Oct 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月24日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Oct. 27, 2025

27 Oct 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended October 24, 2025. In this episode we focus on the most si...

Drug Fix: Another FDA Inspection Reorg, Industry Navigating New DTC Landscape

24 Oct 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs explain the ...

Winning Biotech Investors Through Strategic Partnerships and Trial Innovation

22 Oct 2025

Contributed by Lukas

Biotech funding is tougher than ever, but some companies still win big. Join Claire Riches, VP, Clinical Solutions, Citeline and Alistair McDonald, CE...

Innovating Autoimmune Treatment with In Vivo CAR-T

21 Oct 2025

Contributed by Lukas

As the potential of in vivo CAR-T therapy moves closer to clinical reality, biotech innovators are reimagining what’s possible in autoimmune disease...

How Olon’s fully integrated, end-to-end ADC capabilities drive quality and scale

20 Oct 2025

Contributed by Lukas

Hear experts Matthieu Culié and Alessandro Agosti as they discuss how Olon stands out in a competitive landscape through its fully integrated end-to-...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

20 Oct 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月17日当周的生物制药行业的商业动态。本期节目采用人...